A digital solution dedicated to remote monitoring and support for oncology patients
Let's reinvent the way we treat cancer together
A comprehensive solution to humanize, streamline and personalize care paths
We offer a complete solution comprising two synergistic tools: a remote monitoring platform used by healthcare professionals, and a mobile application to support and help patients live better every day. To pursue our mission, we have set ourselves three key objectives:
- Improving patients' quality of life, adherence to treatment and overall survival.
- Offering users more personalized, more appropriate, more human support.
- Universalizing the cancer care experience so that every patient can benefit.
- Optimizing care and streamlining care paths
- Offering a single pathway and providing the right care at the right time.
- A precise understanding of each patient thanks to the clinical, biological and behavioral data collected.
Suitable for all cancers and treatments
Today, our remote monitoring solution supports thousands of patients. It is suitable for all types of cancer, all phases and all treatments.
Deployed in over 90 healthcare facilities
It is routinely deployed and used on a daily basis in the oncology departments of over 90 private and public healthcare establishments and cancer centers. It serves more than 8,000 patients.
Facilitating care coordination and maintaining links with patients
Proving Resilience's impact on patient health and care organization is at the heart of our approach. To this end, we conduct regular surveys of our users, both caregivers and patients, to better understand the impact of our solution.
In almost 80% of cases, patients feel better taken care of.*.
Some caregivers find that Resilience integrates satisfactorily into their organization*.
Nurses report that Resilience improves communication with their patients.*
* Satisfaction survey conducted by Resilience among caregivers using the solution - December 2022.
First telemonitoring solution for oncology to obtain brand-name reimbursement
On October 24, Resilience received a favorable opinion from the French Health Authority (Haute Autorité de Santé) for the registration of its brand name solution on the Liste des Activités de Télésurveillance Médicale. This makes it the first telemonitoring solution in oncology to be reimbursed on a permanent basis, for all adult patients undergoing systemic treatment.
- Since 2023, telemonitoring has been eligible for reimbursement by the Assurance Maladie, for any patient requiring medical monitoring over a given period.
- Healthcare facilities will therefore be reimbursed for each patient monitored remotely.
Solutions covered by the French health insurance scheme must be CE-marked and comply with the interoperability and security guidelines for telemonitoring digital medical devices defined by the ANS.
- A fixed amount per patient, paid monthly to the telemonitoring operator (medical professional, structure or independent multi-professional team).
- Another flat fee per patient, paid to the operator of the Digital Medical Device, varying according to the type of impact demonstrated to the Haute Autorité de Santé.
To help you claim reimbursement as soon as possible, this guide explains the terms and conditions of reimbursement and the steps you need to take to qualify.
Meet our teams at upcoming events
Amina, Eugénie and Timothée, our Partnership Managers, are at your disposal to inform you about Resilience, remote monitoring in oncology and its impacts.
.webp)
Are you a healthcare professional and want to know more about Resilience? Contact us!
